KCA 098
Gecertificeerd

KCA 098

Catalog #: HY-W746269
Maat: 1 Each

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

KCA 098 is an orally active benzofuroquinoline derivative. KCA 098 can inhibit bone resorption and stimulat bone formation of chick embryo. KCA 098 can increase calcium and phosphorus content as well as the amount of force required to break the femur from ovariectomized rats. KCA 098 can be used for the research of bone diseases[1].

CAS Number

129794-24-7

UNSPSC

12352005

Target

Drug Derivative

Related Pathways

Others

Field of Research

Metabolic Disease

Smiles

O=C(N(C)C)OC1=CC=C2C(OC(C3=C(N4)C=C(OC(N(C)C)=O)C=C3)=C2C4=O)=C1

Molecular Formula

C21H19N3O6

Molecular Weight

409.39

References & Citations

[1]Kojima M, et al. Effect of KCA-098, a new benzofuroquinoline derivative, on bone mineral metabolism. Biol Pharm Bull. 1994 Apr;17 (4) :504-8.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-W746269/

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Beschrijving

KCA 098 is an orally active benzofuroquinoline derivative. KCA 098 can inhibit bone resorption and stimulat bone formation of chick embryo. KCA 098 can increase

Specificaties

ProductnaamKCA 098
Categorie
Beschikbare grootte1 Each
CatalogusnummerHY-W746269